High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma

BACKGROUND: To report on the activity of high-dose prolonged-infusion ifosfamide (HDIFX) chemotherapy in a retrospective series of patients affected by myxoid liposarcoma treated at Fondazione IRCCS Istituto Nazionale dei Tumori in Milan, Italy. PATIENTS AND METHODS: Patients with an advanced myxoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Colia, Vittoria, Fumagalli, Elena, Provenzano, Salvatore, Bertulli, Rossella, Stacchiotti, Silvia, Morosi, Carlo, Collini, Paola, Gronchi, Alessandro, Casali, Paolo G., Sanfilippo, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602616/
https://www.ncbi.nlm.nih.gov/pubmed/28947876
http://dx.doi.org/10.1155/2017/3739159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602616/
https://www.ncbi.nlm.nih.gov/pubmed/28947876
http://dx.doi.org/10.1155/2017/3739159

Ejemplares similares